Literature DB >> 17333356

Changes in GM1 ganglioside content and localization in cholestatic rat liver.

Marie Jirkovská1, Filip Majer, Jaroslava Smídová, Jan Stríteský, Gouse Mohiddin Shaik, Petr Dráber, Libor Vítek, Zdenek Marecek, Frantisek Smíd.   

Abstract

(Glyco)sphingolipids (GSL) are believed to protect the cell against harmful environmental factors by increasing the rigidity of plasma membrane. Marked decrease of membrane fluidity in cholestatic hepatocytes was described but the role of GSL therein has not been investigated so far. In this study, localization in hepatocytes of a representative of GSL, the GM1 ganglioside, was compared between of rats with cholestasis induced by 17alpha-ethinylestradiol (EE) and vehicle propanediol treated or untreated animals. GM1 was monitored by histochemical reaction employing cholera toxin B-subunit. Our findings in normal rat liver tissue showed that GM1 was localized in sinusoidal and canalicular hepatocyte membranes in both peripheral and intermediate zones of the hepatic lobules, and was nearly absent in central zones. On the contrary, in EE-treated animals GM1 was also expressed in central lobular zones. Moreover, detailed densitometry analysis at high magnification showed greater difference of GM1 expression between sinusoidal surface areas and areas of adjacent cytoplasm, caused as well by increased sinusoidal staining in central lobular zone as by decreased staining in cytoplasm in peripheral zone. These differences correlated with serum bile acids as documented by linear regression analyses. Both GM1 content and mRNA corresponding to GM1-synthase remained unchanged in livers; the enhanced expression of GM1 at sinusoidal membrane thus seems to be due to re-distribution of cellular GM1 at limited biosynthesis and could be responsible for protection of hepatocytes against harmful effects of bile acids accumulated during cholestasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17333356     DOI: 10.1007/s10719-007-9030-7

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   3.009


  24 in total

Review 1.  Crystal structures of membrane lipids.

Authors:  I Pascher; M Lundmark; P G Nyholm; S Sundell
Journal:  Biochim Biophys Acta       Date:  1992-12-11

Review 2.  Structure and function of gangliosides.

Authors:  G Tettamanti; M Masserini; A Giuliani; A Pagani
Journal:  Ann Ist Super Sanita       Date:  1988       Impact factor: 1.663

3.  Transcytotic vesicle fusion is reduced in cholestatic rats: redistribution of phospholipids in the canalicular membrane.

Authors:  H Hyogo; S Tazuma; G Kajiyama
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

4.  Increased cholesterol and decreased fluidity of red cell membranes (spur cell anemia) in progressive intrahepatic cholestasis.

Authors:  W F Balistreri; M H Leslie; R A Cooper
Journal:  Pediatrics       Date:  1981-04       Impact factor: 7.124

5.  Correlation between serum alkaline phosphatase and localization of alkaline phosphatase in the liver.

Authors:  J Koudstaal; A P Runsink; M van der Sandt; M J Hardonk
Journal:  Acta Histochem Suppl       Date:  1975

Review 6.  Cholestasis: human disease and experimental animal models.

Authors:  Emilio Alberto Rodríguez-Garay
Journal:  Ann Hepatol       Date:  2003 Oct-Dec       Impact factor: 2.400

7.  Quantification of gangliotetraose gangliosides with cholera toxin.

Authors:  G S Wu; R Ledeen
Journal:  Anal Biochem       Date:  1988-09       Impact factor: 3.365

8.  Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae.

Authors:  R G Parton
Journal:  J Histochem Cytochem       Date:  1994-02       Impact factor: 2.479

9.  Electron paramagnetic resonance studies on the fluidity and surface dynamics of egg phosphatidylcholine vesicles containing gangliosides.

Authors:  E Bertoli; M Masserini; S Sonnino; R Ghidoni; B Cestaro; G Tettamanti
Journal:  Biochim Biophys Acta       Date:  1981-10-02

10.  Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.

Authors:  M Arrese; M Pizarro; N Solís; C Koenig; L Accatino
Journal:  Biochem Pharmacol       Date:  1995-10-12       Impact factor: 5.858

View more
  4 in total

Review 1.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

2.  Histochemical detection of GM1 ganglioside using cholera toxin-B subunit. Evaluation of critical factors optimal for in situ detection with special emphasis to acetone pre-extraction.

Authors:  T Petr; V Smíd; J Smídová; H Hůlková; M Jirkovská; M Elleder; L Muchová; L Vitek; F Smíd
Journal:  Eur J Histochem       Date:  2010-05-12       Impact factor: 3.188

3.  Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.

Authors:  Lucie Muchova; Katerina Vanova; Jakub Suk; Stanislav Micuda; Eva Dolezelova; Leos Fuksa; Dalibor Cerny; Hassan Farghali; Miroslava Zelenkova; Martin Lenicek; Ronald J Wong; Hendrik J Vreman; Libor Vitek
Journal:  J Cell Mol Med       Date:  2015-02-16       Impact factor: 5.310

4.  Heme Oxygenase-1 May Affect Cell Signalling via Modulation of Ganglioside Composition.

Authors:  Václav Šmíd; Jakub Šuk; Neli Kachamakova-Trojanowska; Jana Jašprová; Petra Valášková; Alicja Józkowicz; Józef Dulak; František Šmíd; Libor Vítek; Lucie Muchová
Journal:  Oxid Med Cell Longev       Date:  2018-09-19       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.